author-photo

Ellen K. Ritchie

Cornell University
NewYork–Presbyterian Hospital

225

Papers

4260

Citations

Citation Trend

Filter By

Papers (160) Sort By

Journal Conference Others

Safety and Efficacy of Lower Intensity Induction Therapy with Intravenous Prexigebersen (BP1001) in Patients with High-Risk and Relapsed/Refractory Acute Myeloid Leukemia (AML)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Hematopoietic Stem and Progenitor Cell Fitness As a Novel Prognostic and Monitoring Biomarker for JAK2 V617F Myeloproliferative Neoplasms (MPNs)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Venetoclax in Combination with Gilteritinib Demonstrates Molecular Clearance of FLT3 mutation in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (3)
Hematopoietic fitness of JAK2V617F Myeloproliferative Neoplasms is linked to clinical outcome

2021 medRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Community Versus Academic Practice in Essential Thrombocythemia and Myelofibrosis: Differences in Clinical Characteristics, Diagnosis, Treatment Patterns, and Symptom Burden (Analysis of Data from the MOST Study)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial

2021 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (4)
Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell Transplant

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival.

2021 Leukemia
Show All
- Source
- Cite
- Save
Citations (8)
Comparing Outcomes between Liposomal Daunorubicin/Cytarabine (CPX-351) and HMA+Venetoclax As Frontline Therapy in Acute Myeloid Leukemia

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)